SRF ID: 0100500051156

Name of Patient : Mr. Ravtej Singh Test Request ID : 28822104150054

Age/Gender : 20 Yrs/Male Specimen Drawn ON : 20-June-2021 01:00PM
Collected AT : CRL COLLECTION POINT Specimen Received ON : 21-June-2021 03:06PM
Referred BY : NA Report DATE : 21-June-2021 07:04AM
Sample Type : - 30592635
Ref Customer :

Molecular Biology
Test Description Observed Value Biological Reference Range
SARS - COV -2 REAL TIME PCR
SARS COV- 2
NOT DETECTED NOT DETECTED
RNA
REAL TIME RT PCR

SARS CoV-2 (RdRp Gene) NOT DETECTED

β CoV-2 (E Gene) NOT DETECTED
NOTE - ICMR REGISTERATION NUMBER - CRLDPLD

Interpretation -
SARS COV -2 REAL TIME PCR-
SARS-CoV-2, formerlyknown as 2019-nCoV, is the causative agent of the coronavirus disease 2019 (COVID-19). Main symptoms of
the disease include fever, cough and shortness of breath. The virus is spread via person-to-person contact through respiratory droplets
produced when a person coughs or sneezes. The SARS-CoV-2 RNA is generally detectable in nasopharyngeal/oropharyngeal swabs
duringthe acute phase of infection. Positive results are indicative of active infection. Real Time PCRassaytargets E and RdRp/S gene
and can be used for diagnosis of SARS-CoV-2 virus infection which contributes to severe upper respiratory distress, complications
Methodology: Real Time PCR Interpretation:
Detected result is considered a positive test result for COVID-19. This indicates that RNA from SARS-CoV-2 was detected, and the
patient is considered infected with the virus and presumed to be contagious.
Not Detected test result for this test means that SARS-CoV-2 RNA was not present in the specimen above the limit of detection.

Limitations:
• Negative results donot preclude COVID-19 and should not be used as the sole basis for patient management decisions.
Negative results must be combined with clinical observations, patienthistory, and epidemiological information.
• Positive results but do not rule out bacterial infection or co-infection with other viruses.
• Optimum specimen types andtiming for peak viral levels duringinfections caused by 2019-nCoV have not been determined.
Collection of multiple specimens (types and time points) from the same patient may be necessaryto detect the virus.
• If the virus mutates in therRT-PCRtarget region, 2019-nCoV maynot be detected or may be detected less predictably. Inhibitors
or other types of interference mayproduce a false negative result.
• The performance of this test hasnot been established for monitoring treatment of 2019-nCoV infection.

Note: Test is performed using ICMRapproved Kit. References:

1. Laboratorytesting for coronavirus disease 2019 (COVID-19) in suspected human cases. Interim guidance. World Health Organization.
2. Druce et al. JCM. 2011
3. N. Engl. J. Med. 2020, 382, 929–936

*Not in NABL Scope.

*** End Of Report ***
Disclaimer:-For test performed on specimens received or collected from non-CRL locations, it is presumed that the specimen belongs to the patient named or identified as labeled on the container/test request and such verification has been carried Page 1 of 1
out at the point generation of the said specimen by the sender. CRL will be responsible Onlyfor the analytical part of test carried out. All other responsibility will be of referring Laboratory.